Pacific Biosciences of California IDIQ   2

Background
The United States Department of Agriculture (USDA), Agricultural Research Service (ARS) intends to award a single source contract to Pacific Biosciences of California, Inc. (PacBio) for an Indefinite Delivery Indefinite Quantity (IDIQ) contract.

This initiative is part of a strategic sourcing effort aimed at improving administrative efficiencies and is based on the significant quantities of scientific equipment, reagents, and services that USDA has historically purchased from PacBio. The IDIQ contract is intended for use by any USDA agency and is scheduled to expire in June 2026.

Work Details
The IDIQ contract will cover the procurement of equipment, supplies, and support plans specifically related to PacBio's Revio and Vega DNA sequencing product family.

The contractor will be responsible for providing a current product price schedule, which will be incorporated into the resultant IDIQ contract. The scope includes:
- Equipment and reagents necessary for ongoing research projects.
- Instrument support plans.
- Quarterly updates to the IDIQ to reflect any changes in product availability.
- A requirement for service agreements as needed at the time of order placement.

Period of Performance
The period of performance for this contract is from July 1, 2026, to June 30, 2031.

Place of Performance
The products and services will be delivered to various USDA agency locations as specified in individual task orders.

Bidder Requirements
Bidders must demonstrate their capability to meet the requirements outlined in the solicitation. Specific requirements include providing a completed price list and maintaining acceptable past performance records with prior contracts/orders with USDA.

The acquisition is unrestricted; however, bidders must submit pricing for all items listed in the solicitation.

Incumbent Analysis (see Incumbents section for more detail)
This opportunity appears to have a confirmed incumbent, as USDA ARS previously awarded Pacific Biosciences of California an IDIQ contract (12405B21D0002) valued at $8,529,846 for 07/01/21–06/30/26. That prior work covered long-read sequencing equipment, reagents, and services for PacBio systems including Sequel/Sequel II and Revio, along with instrument support such as service agreements and maintenance. The current IDIQ similarly focuses on procurement of equipment, reagents, and support plans for the Revio and Vega product family, which appears to be a continuation/expansion of the same sequencing platform supply-and-support requirement.